149 related articles for article (PubMed ID: 10700909)
1. [Combination of levofolinate calcium and 5-fluorouracil].
Sasaki T
Gan To Kagaku Ryoho; 2000 Feb; 27(2):315-22. PubMed ID: 10700909
[TBL] [Abstract][Full Text] [Related]
2. [Leucovorin and 5-FU for advanced gastrointestinal cancer].
Sasaki T; Maeda Y; Kobayashi T
Gan To Kagaku Ryoho; 1999 Mar; 26(4):440-6. PubMed ID: 10097740
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy for gastric cancer including LV/5-FU].
Sasaki T; Maeda Y; Kandaba-shi K; Ono M
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1952-6. PubMed ID: 15570919
[TBL] [Abstract][Full Text] [Related]
4. [The biochemical modulation of 5-fluorouracil by leucovorin].
Borner M; Brunner K
Schweiz Med Wochenschr; 1991 Aug; 121(33):1149-56. PubMed ID: 1925442
[TBL] [Abstract][Full Text] [Related]
5. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
6. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
Uemura N; Yamada Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of hepatic arterial infusion chemotherapy with levofolinate (l-LV) and 5-fluorouracil (5-FU) for multiple liver metastases from colorectal cancer].
Soma I; Kanai T; Fukuchi N; Izawa H; Yoshida T; Ebisui C; Sakita I; Fujimoto T
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2121-3. PubMed ID: 12484017
[TBL] [Abstract][Full Text] [Related]
8. [A case of rectal cancer with distant lymph node metastases completely responding to postoperative chemotherapy with levofolinate combined with 5-fluorouracil].
Jingu K; Nakajima Y; Inoue M; Ochiai T
Gan To Kagaku Ryoho; 2004 Jan; 31(1):117-9. PubMed ID: 14750335
[TBL] [Abstract][Full Text] [Related]
9. Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer.
Tsavaris N; Kosmas C; Gennatas K; Vadiaka M; Paliaros P; Dimitrakopoulos A; Diamantis T; Tsipras H; Papastratis G
Med Sci Monit; 2002 Sep; 8(9):PI65-9. PubMed ID: 12218954
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical modulation--the historical background].
Tsukagoshi S
Gan To Kagaku Ryoho; 1992 Jul; 19(7):941-5. PubMed ID: 1626949
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical modulation of 5-fluorouracil by high-dose leucovorin].
Aiba K
Gan To Kagaku Ryoho; 1988 Mar; 15(3):392-408. PubMed ID: 3279911
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer].
Terashima M; Ikeda K; Kawamura H; Maesawa C; Takiyama I; Yoshinari H; Koeda K; Sato N; Ishida K; Saito K
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1999-2004. PubMed ID: 1417007
[TBL] [Abstract][Full Text] [Related]
13. [FOLFOX].
Mishima H; Ikenaga M; Tsujinaka T; Yasui M; Kashiwazaki M; Miyazaki M; Hirao M; Fujitani K; Nakamori S
Gan To Kagaku Ryoho; 2006 Jul; 33(7):911-4. PubMed ID: 16835479
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
15. [Method of levofolinate.5-FU administration by hepatic arterial infusion therapy for hepatic metastasis from colorectal cancer].
Shimomatsuya T; Kobuchi T; Kitamura N; Hata K; Nakamura T; Shiraishi S; Fujino H; Maruhashi K
Gan To Kagaku Ryoho; 2006 Feb; 33(2):213-6. PubMed ID: 16484858
[TBL] [Abstract][Full Text] [Related]
16. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Saltz LB; Niedzwiecki D; Hollis D; Goldberg RM; Hantel A; Thomas JP; Fields AL; Mayer RJ
J Clin Oncol; 2007 Aug; 25(23):3456-61. PubMed ID: 17687149
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
[TBL] [Abstract][Full Text] [Related]
18. 5-FU/leucovorin: biochemical modulation that works?
Arbuck SG
Oncology (Williston Park); 1987 Apr; 1(2):61-74. PubMed ID: 3079477
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
[TBL] [Abstract][Full Text] [Related]
20. [A case of gastric cancer with multiple liver metastases responding to combined hepatic arterial and aortic infusion chemotherapy with cisplatinum, 5-fluorouracil, and levofolinate calcium].
Sugita M; Togo S; Tanaka K; Miura Y; Akiyama H; Nomura M; Kunisaki C; Shimada H
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1835-9. PubMed ID: 12402439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]